Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  23,198 results for ""GLUCOSAMINE""

Your Filters

Publisher : wiley-blackwell
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Habitual use of glucosamine and adverse liver outcomes among patients with type 2 diabetes and MASLD.

  • Authors : Shen Y; Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai, China.; Chronic Disease Epidemiology, Pennington Biomedical Researcher Center, Baton Rouge, Louisiana, USA.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Glucosamine*/Glucosamine*/Glucosamine*/therapeutic use ; Glucosamine*/Glucosamine*/Glucosamine*/adverse effects

  • Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Sep; Vol. 44 (9), pp. 2359-2367. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Green synthesis of glyco-phenol by enzymatic coupling between ferulic acid and glucosamine: An ecofriendly procedure.

  • Authors : Aljawish A; Laboratory of Biomolecules Engineering (LIBio), Lorraine University, Vandœuvre-lès-Nancy, France.; Chevalot I

Subjects: Glucosamine* ; Phenol*; Coumaric Acids/Coumaric Acids/Coumaric Acids/chemistry

  • Source: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2022 Aug; Vol. 69 (4), pp. 1438-1450. Date of Electronic Publication: 2021 Jul 05.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8609465 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Glucosamine protects against radiation-induced lung injury via inhibition of epithelial-mesenchymal transition.

  • Authors : Lei X; Department of Radiation Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.; Ma N

Subjects: Alveolar Epithelial Cells/Alveolar Epithelial Cells/Alveolar Epithelial Cells/*drug effects ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Epithelial-Mesenchymal Transition/Epithelial-Mesenchymal Transition/Epithelial-Mesenchymal Transition/*drug effects

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2020 Sep; Vol. 24 (18), pp. 11018-11023. Date of Electronic Publication: 2020 Jul 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Molecular docking-guided synthesis of NSAID-glucosamine bioconjugates and their evaluation as COX-1/COX-2 inhibitors with potentially reduced gastric toxicity.

  • Authors : Jones Lipinski RA; Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL, USA.; Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*chemistry ; Cyclooxygenase 1/Cyclooxygenase 1/Cyclooxygenase 1/*metabolism ; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*metabolism

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2021 Jul; Vol. 98 (1), pp. 102-113. Date of Electronic Publication: 2021 May 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print-Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial.

  • Authors : Jin SY; Department of Dermatology, Dongguk University Ilsan Hospital, Dongguk University Graduate School of Medicine, Gyeonggi-do, South Korea.; Lim WS

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*therapeutic use ; Dermatitis, Atopic/Dermatitis, Atopic/Dermatitis, Atopic/*drug therapy ; Dermatologic Agents/Dermatologic Agents/Dermatologic Agents/*therapeutic use

  • Source: Dermatologic therapy [Dermatol Ther] 2015 Jan-Feb; Vol. 28 (1), pp. 44-51. Date of Electronic Publication: 2014 Aug 12.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Dietary supplement and complementary and alternative medicine use among older adults in Australia and the United States.

Subjects: GLUCOSAMINE; VITAMINS; FRAIL elderlyAUSTRALIA; UNITED States

  • Source: Journal of the American Geriatrics Society. Jul2023, Vol. 71 Issue 7, p2219-2228. 10p.

Record details

Read More Add to Saved list
×
Academic Journal

Efficient production of D-glucosaminic acid from D-glucosamine by Pseudomonas putida GNA5.

  • Authors : Wu B; College of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing 210009, Jiangsu, China.; Bai Z

Subjects: Glucosamine/Glucosamine/Glucosamine/*analogs & derivatives ; Glucosamine/Glucosamine/Glucosamine/*metabolism ; Pseudomonas putida/Pseudomonas putida/Pseudomonas putida/*metabolism

  • Source: Biotechnology progress [Biotechnol Prog] 2011 Jan-Feb; Vol. 27 (1), pp. 32-7. Date of Electronic Publication: 2010 Dec 23.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8506292 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Can treatment with chondroitin and glucosamine sulphate prevent changes in the articular disc caused by temporomandibular joint osteoarthritis?

Subjects: TEMPOROMANDIBULAR disorders; TEMPOROMANDIBULAR joint; RESEARCH funding

  • Source: Journal of Oral Rehabilitation; Nov2024, Vol. 51 Issue 11, p2289-2296, 8p

Record details

Read More Add to Saved list
×
Academic Journal

Risk factors for magnetic resonance imaging-detected patellofemoral and tibiofemoral cartilage loss during a six-month period: the joints on glucosamine study.

  • Authors : Roemer FW; Boston University Medical Center, Boston, MA, USA. ; Kwoh CK

Subjects: Cartilage, Articular/Cartilage, Articular/Cartilage, Articular/*pathology ; Chronic Pain/Chronic Pain/Chronic Pain/*pathology ; Glucosamine/Glucosamine/Glucosamine/*pharmacology

  • Source: Arthritis and rheumatism [Arthritis Rheum] 2012 Jun; Vol. 64 (6), pp. 1888-98. Date of Electronic Publication: 2011 Dec 27.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis.

  • Authors : Wang SX; University of Toronto, Toronto, Ontario, Canada.; Laverty S

Subjects: Bone and Bones/Bone and Bones/Bone and Bones/*drug effects ; Glucosamine/Glucosamine/Glucosamine/*pharmacology ; Osteoarthritis, Knee/Osteoarthritis, Knee/Osteoarthritis, Knee/*pathology

  • Source: Arthritis and rheumatism [Arthritis Rheum] 2007 May; Vol. 56 (5), pp. 1537-48.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  23,198 results for ""GLUCOSAMINE""